In vitro interactions of Candida parapsilosis wild type and lipase deficient mutants with human monocyte derived dendritic cells

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Nagy, István ^a   Filkor, Kata ^a   Németh, Tibor ^b   Hamari, Zsuzsanna ^b   Vágvölgyi, Csaba ^b   Gácser, Attila ^b  

^a BAY ZOLTÁN NONPROFIT LTD FOR APPLIED RESEARCH   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Candida; dendritic cell; innate immunity; secreted lipase

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; VIRULENCE FACTOR;

ANTIFUNGAL ACTIVITY; ARTICLE; CELL INTERACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGAL CELL; FUNGAL STRAIN; GENE EXPRESSION; HOST CELL; IN VITRO STUDY; LIPASE DEFICIENT MUTANT CANDIDA PARAPSILOSIS CELL; MONOCYTE DERIVED DENDRITIC CELL; NONHUMAN; PHAGOCYTOSIS; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WILD TYPE; WILD TYPE CANDIDA PARAPSILOSIS CELL; CANDIDA; ENZYMOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; SECRETION;

CANDIDA; CANDIDA PARAPSILOSIS;

CANDIDA; CYTOKINES; DENDRITIC CELLS; HUMANS; LIPASE; MICROBIAL VIABILITY; PHAGOCYTOSIS; VIRULENCE FACTORS;

EID: 79957518864     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-122     Document Type: Article

References (27)

1. Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility. EC van Asbeck KV Clemons DA Stevens, Crit Rev Microbiol 2009 35 283 309 10.3109/10408410903213393 19821642
2. International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). MA Pfaller RN Jones GV Doern AC Fluit J Verhoef HS Sader SA Messer A Houston S Coffman RJ Hollis, Diagn Microbiol Infect Dis 1999 35 19 25 10.1016/S0732-8893(99)00046-2 10529877 (Pubitemid 29435937)
3. Candida parapsilosis, an emerging fungal pathogen. D Trofa A Gacser JD Nosanchuk, Clin Microbiol Rev 2008 21 606 625 10.1128/CMR.00013-08 18854483
4. Candida Bloodstream Infections: Comparison of Species Distribution and Antifungal Resistance in Community Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program (2008-2009). MA Pfaller GJ Moet SA Messer RN Jones M Castanheira, Antimicrob Agents Chemother 2010
5. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. TA Clark SA Slavinski J Morgan T Lott BA Arthington-Skaggs ME Brandt RM Webb M Currier RH Flowers SK Fridkin RA Hajjeh, J Clin Microbiol 2004 42 4468 4472 10.1128/JCM.42.10.4468-4472.2004 15472295 (Pubitemid 39362357)
6. Candida parapsilosis infection in very low birthweight infants. L Clerihew TL Lamagni P Brocklehurst W McGuire, Arch Dis Child Fetal Neonatal Ed 2007 92 127 129 10.1136/fnn.2006.097758 17337658
7. Candida bloodstream infection in neonates. DK Benjamin Jr H Garges WJ Steinbach, Semin Perinatol 2003 27 375 383 10.1016/S0146-0005(03)00061-2 14626501 (Pubitemid 37363190)
8. Neonatal candidiasis. PB Smith WJ Steinbach DK Benjamin Jr, Infect Dis Clin North Am 2005 19 603 615 10.1016/j.idc.2005.05.007 16102651 (Pubitemid 41133531)
9. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. SL Newman A Holly, Infect Immun 2001 69 6813 6822 10.1128/IAI.69.11.6813-6822.2001 11598054 (Pubitemid 32995440)
10. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. A Pivarcsi L Bodai B Rethi A Kenderessy-Szabo A Koreck M Szell Z Beer Z Bata-Csorgoo M Magocsi E Rajnavolgyi A Dobozy L Kemeny, Int Immunol 2003 15 721 730 10.1093/intimm/dxg068 12750356 (Pubitemid 36675803)
11. An integrated model of the recognition of Candida albicans by the innate immune system. MG Netea GD Brown BJ Kullberg NA Gow, Nat Rev Microbiol 2008 6 67 78 10.1038/nrmicro1815 18079743 (Pubitemid 350286221)
12. A novel pseudopodial component of the dendritic cell anti-fungal response: the fungipod. AK Neumann K Jacobson, PLoS Pathog 2010 6 1000760 10.1371/journal.ppat.1000760 20169183
13. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. A Gacser D Trofa W Schafer JD Nosanchuk, J Clin Invest 2007 117 3049 3058 10.1172/JCI32294 17853941 (Pubitemid 47529634)
14. Lipase 8 affects the pathogenesis of Candida albicans. A Gacser F Stehr C Kroger L Kredics W Schafer JD Nosanchuk, Infect Immun 2007 75 4710 4718 10.1128/IAI.00372-07 17646357 (Pubitemid 47502140)
15. Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages. MG Netea K Gijzen N Coolen I Verschueren C Figdor JW Van der Meer R Torensma BJ Kullberg, Microbes Infect 2004 6 985 989 10.1016/j.micinf.2004.05.013 15345229 (Pubitemid 39166039)
16. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. X Shao A Mednick M Alvarez N van Rooijen A Casadevall DL Goldman, J Immunol 2005 175 3244 3251 16116215 (Pubitemid 41170545)
17. The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. O Zaragoza M Alvarez A Telzak J Rivera A Casadevall, Infect Immun 2007 75 2729 2739 10.1128/IAI.00094-07 17371865 (Pubitemid 46870153)
18. Dendritic cells at the host-pathogen interface. M Colonna B Pulendran A Iwasaki, Nat Immunol 2006 7 117 120 10.1038/ni0206-117 16424884 (Pubitemid 43135873)
19. Direct transformation of a clinical isolate of Candida parapsilosis using a dominant selection marker. A Gacser S Salomon W Schafer, FEMS Microbiol Lett 2005 245 117 121 10.1016/j.femsle.2005.02.035 15796988 (Pubitemid 40410684)
20. Histoplasma capsulatum modulates the acidification of phagolysosomes. LG Eissenberg WE Goldman PH Schlesinger, J Exp Med 1993 177 1605 1611 10.1084/jem.177.6.1605 8496679 (Pubitemid 23146127)
21. A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages. L Shi PC Albuquerque E Lazar-Molnar X Wang L Santambrogio A Gacser JD Nosanchuk, Eukaryot Cell 2008 7 1109 1117 10.1128/EC.00036-08 18487350 (Pubitemid 351969325)
22. Candida albicans actively modulates intracellular membrane trafficking in mouse macrophage phagosomes. E Fernandez-Arenas CK Bleck C Nombela C Gil G Griffiths R Diez-Orejas, Cell Microbiol 2009 11 560 589 10.1111/j.1462-5822. 2008.01274.x 19134116
23. Analysis of PRA1 and its relationship to Candida albicans- macrophage interactions. A Marcil C Gadoury J Ash J Zhang A Nantel M Whiteway, Infect Immun 2008 76 4345 4358 10.1128/IAI.00588-07 18625733
24. Immunology. Danger, microbes, and homeostasis. BP Lazzaro J Rolff, Science 2011 332 43 44 10.1126/science.1200486 21454776
25. The danger model: a renewed sense of self. P Matzinger, Science 2002 296 301 305 10.1126/science.1071059 11951032 (Pubitemid 34303674)
26. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. RM Strieter SL Kunkel HJ Showell DG Remick SH Phan PA Ward RM Marks, Science 1989 243 1467 1469 10.1126/science.2648570 2648570 (Pubitemid 19087129)
27. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. AY Liu D Destoumieux AV Wong CH Park EV Valore L Liu T Ganz, J Invest Dermatol 2002 118 275 281 10.1046/j.0022-202x.2001.01651.x 11841544 (Pubitemid 34158481)